Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1473069

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1473069

North America Serum Separation Gel Market Size, Share & Trends Analysis Report By Product Type (Serum Separation Gel Integrated with Tube, and Serum Separation Gel Integrated without Tube), By End User, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 107 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The North America Serum Separation Gel Market would witness market growth of 5.9% CAGR during the forecast period (2024-2031).

The US market dominated the North America Serum Separation Gel Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,108.5 million by 2031. The Canada market is experiencing a CAGR of 8.3% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.4% during (2024 - 2031).

Laboratories increasingly adopt automated blood collection and processing systems, often incorporating serum separation technology. Automated platforms streamline sample handling, improve workflow efficiency, and reduce the risk of human errors. As the demand for high-throughput diagnostic testing grows, automated solutions for serum separation are becoming more prevalent in clinical laboratories and blood banks. Point-of-care testing devices that utilize serum or plasma samples are gaining popularity due to their ability to deliver rapid results at the patient's bedside or in remote settings.

Additionally, Serum separation gel plays a role in enabling sample preparation for certain POCT devices, contributing to the accuracy and reliability of test results. The rising number of chronic diseases and the need for timely diagnosis and monitoring drive the demand for POCT devices and serum separation products compatible with these platforms.

According to the Centers for Disease Control and Prevention, six out of ten Americans suffer from at least one chronic condition, including diabetes, cancer, heart disease, or a stroke. The leading causes of death and disability in the US are these and other chronic disorders, dramatically raising healthcare costs. North America has a significant aging population, with a growing number of older adults experiencing age-related chronic conditions and comorbidities. Hence, the factors mentioned above will drive the regional market growth.

Based on Product Type, the market is segmented into Serum Separation Gel Integrated with Tube, and Serum Separation Gel Integrated without Tube. Based on End User, the market is segmented into Blood Bank, Hospital, Pharmaceutical & Companies, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Becton, Dickinson, and Company
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Siemens Healthineers AG (Siemens AG)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Charles River Laboratories International, Inc.
  • QuidelOrtho Corporation

North America Serum Separation Gel Market Report Segmentation

By Product Type

  • Serum Separation Gel Integrated with Tube
  • Serum Separation Gel Integrated without Tube

By End User

  • Blood Bank
  • Hospital
  • Pharmaceutical & Companies
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1North America Serum Separation Gel Market, by Product Type
    • 1.4.2North America Serum Separation Gel Market, by End User
    • 1.4.3North America Serum Separation Gel Market, by Country
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.North America Serum Separation Gel Market by Product Type

  • 4.1North America Serum Separation Gel Integrated with Tube Market by Region
  • 4.2North America Serum Separation Gel Integrated without Tube Market by Region

Chapter 5.North America Serum Separation Gel Market by End User

  • 5.1North America Blood Bank Market by Country
  • 5.2North America Hospital Market by Country
  • 5.3North America Pharmaceutical & Companies Market by Country
  • 5.4North America Others Market by Country

Chapter 6.North America Serum Separation Gel Market by Country

  • 6.1US Serum Separation Gel Market
    • 6.1.1US Serum Separation Gel Market by Product Type
    • 6.1.2US Serum Separation Gel Market by End User
  • 6.2Canada Serum Separation Gel Market
    • 6.2.1Canada Serum Separation Gel Market by Product Type
    • 6.2.2Canada Serum Separation Gel Market by End User
  • 6.3Mexico Serum Separation Gel Market
    • 6.3.1Mexico Serum Separation Gel Market by Product Type
    • 6.3.2Mexico Serum Separation Gel Market by End User
  • 6.4Rest of North America Serum Separation Gel Market
    • 6.4.1Rest of North America Serum Separation Gel Market by Product Type
    • 6.4.2Rest of North America Serum Separation Gel Market by End User

Chapter 7.Company Profiles

  • 7.1Becton, Dickinson, and Company
    • 7.1.1Company Overview
    • 7.1.2Financial Analysis
    • 7.1.3Segmental and Regional Analysis
    • 7.1.4Research & Development Expense
    • 7.1.5SWOT Analysis
  • 7.2F. Hoffmann-La Roche Ltd.
    • 7.2.1Company Overview
    • 7.2.2Financial Analysis
    • 7.2.3Segmental and Regional Analysis
    • 7.2.4Research & Development Expense
    • 7.2.5SWOT Analysis
  • 7.3Abbott Laboratories
    • 7.3.1Company Overview
    • 7.3.2Financial Analysis
    • 7.3.3Segmental and Regional Analysis
    • 7.3.4Research & Development Expense
    • 7.3.5SWOT Analysis
  • 7.4Agilent Technologies, Inc.
    • 7.4.1Company Overview
    • 7.4.2Financial Analysis
    • 7.4.3Segmental and Regional Analysis
    • 7.4.4Research & Development Expense
    • 7.4.5Recent strategies and developments:
      • 7.4.5.1Acquisition and Mergers:
    • 7.4.6SWOT Analysis
  • 7.5Siemens Healthineers AG (Siemens AG)
    • 7.5.1Company Overview
    • 7.5.2Financial Analysis
    • 7.5.3Segmental and Regional Analysis
    • 7.5.4Research & Development Expense
    • 7.5.5Recent strategies and developments:
      • 7.5.5.1Partnerships, Collaborations, and Agreements:
    • 7.5.6SWOT Analysis
  • 7.6Bio-Rad laboratories, Inc.
    • 7.6.1Company Overview
    • 7.6.2Financial Analysis
    • 7.6.3Segmental and Regional Analysis
    • 7.6.4Research & Development Expenses
    • 7.6.5Recent strategies and developments:
      • 7.6.5.1Partnerships, Collaborations, and Agreements:
      • 7.6.5.2Product Launches and Product Expansions:
    • 7.6.6SWOT Analysis
  • 7.7Danaher Corporation
    • 7.7.1Company Overview
    • 7.7.2Financial Analysis
    • 7.7.3Segmental and Regional Analysis
    • 7.7.4Research & Development Expense
    • 7.7.5SWOT Analysis
  • 7.8Sysmex Corporation
    • 7.8.1Company Overview
    • 7.8.2Financial Analysis
    • 7.8.3Regional Analysis
    • 7.8.4Research & Development Expense
    • 7.8.5SWOT Analysis
  • 7.9Charles River Laboratories International, Inc.
    • 7.9.1Company Overview
    • 7.9.2Financial Analysis
    • 7.9.3Segmental and Regional Analysis
    • 7.9.4SWOT Analysis
  • 7.10.QuidelOrtho Corporation
    • 7.10.1Company Overview
    • 7.10.2Financial Analysis
    • 7.10.3Regional Analysis
    • 7.10.4Research & Development Expense
    • 7.10.5SWOT Analysis

LIST OF TABLES

  • TABLE 1North America Serum Separation Gel Market, 2020 - 2023, USD Million
  • TABLE 2North America Serum Separation Gel Market, 2024 - 2031, USD Million
  • TABLE 3North America Serum Separation Gel Market by Product Type, 2020 - 2023, USD Million
  • TABLE 4North America Serum Separation Gel Market by Product Type, 2024 - 2031, USD Million
  • TABLE 5North America Serum Separation Gel Integrated with Tube Market by Region, 2020 - 2023, USD Million
  • TABLE 6North America Serum Separation Gel Integrated with Tube Market by Region, 2024 - 2031, USD Million
  • TABLE 7North America Serum Separation Gel Integrated without Tube Market by Region, 2020 - 2023, USD Million
  • TABLE 8North America Serum Separation Gel Integrated without Tube Market by Region, 2024 - 2031, USD Million
  • TABLE 9North America Serum Separation Gel Market by End User, 2020 - 2023, USD Million
  • TABLE 10North America Serum Separation Gel Market by End User, 2024 - 2031, USD Million
  • TABLE 11North America Blood Bank Market by Country, 2020 - 2023, USD Million
  • TABLE 12North America Blood Bank Market by Country, 2024 - 2031, USD Million
  • TABLE 13North America Hospital Market by Country, 2020 - 2023, USD Million
  • TABLE 14North America Hospital Market by Country, 2024 - 2031, USD Million
  • TABLE 15North America Pharmaceutical & Companies Market by Country, 2020 - 2023, USD Million
  • TABLE 16North America Pharmaceutical & Companies Market by Country, 2024 - 2031, USD Million
  • TABLE 17North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 18North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 19North America Serum Separation Gel Market by Country, 2020 - 2023, USD Million
  • TABLE 20North America Serum Separation Gel Market by Country, 2024 - 2031, USD Million
  • TABLE 21US Serum Separation Gel Market, 2020 - 2023, USD Million
  • TABLE 22US Serum Separation Gel Market, 2024 - 2031, USD Million
  • TABLE 23US Serum Separation Gel Market by Product Type, 2020 - 2023, USD Million
  • TABLE 24US Serum Separation Gel Market by Product Type, 2024 - 2031, USD Million
  • TABLE 25US Serum Separation Gel Market by End User, 2020 - 2023, USD Million
  • TABLE 26US Serum Separation Gel Market by End User, 2024 - 2031, USD Million
  • TABLE 27Canada Serum Separation Gel Market, 2020 - 2023, USD Million
  • TABLE 28Canada Serum Separation Gel Market, 2024 - 2031, USD Million
  • TABLE 29Canada Serum Separation Gel Market by Product Type, 2020 - 2023, USD Million
  • TABLE 30Canada Serum Separation Gel Market by Product Type, 2024 - 2031, USD Million
  • TABLE 31Canada Serum Separation Gel Market by End User, 2020 - 2023, USD Million
  • TABLE 32Canada Serum Separation Gel Market by End User, 2024 - 2031, USD Million
  • TABLE 33Mexico Serum Separation Gel Market, 2020 - 2023, USD Million
  • TABLE 34Mexico Serum Separation Gel Market, 2024 - 2031, USD Million
  • TABLE 35Mexico Serum Separation Gel Market by Product Type, 2020 - 2023, USD Million
  • TABLE 36Mexico Serum Separation Gel Market by Product Type, 2024 - 2031, USD Million
  • TABLE 37Mexico Serum Separation Gel Market by End User, 2020 - 2023, USD Million
  • TABLE 38Mexico Serum Separation Gel Market by End User, 2024 - 2031, USD Million
  • TABLE 39Rest of North America Serum Separation Gel Market, 2020 - 2023, USD Million
  • TABLE 40Rest of North America Serum Separation Gel Market, 2024 - 2031, USD Million
  • TABLE 41Rest of North America Serum Separation Gel Market by Product Type, 2020 - 2023, USD Million
  • TABLE 42Rest of North America Serum Separation Gel Market by Product Type, 2024 - 2031, USD Million
  • TABLE 43Rest of North America Serum Separation Gel Market by End User, 2020 - 2023, USD Million
  • TABLE 44Rest of North America Serum Separation Gel Market by End User, 2024 - 2031, USD Million
  • TABLE 45Key Information - Becton, Dickinson and Company
  • TABLE 46Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 47Key Information - Abbott Laboratories
  • TABLE 48key Information - Agilent Technologies, Inc.
  • TABLE 49Key Information - Siemens Healthineers AG
  • TABLE 50Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 51Key Information - Danaher Corporation
  • TABLE 52Key Information - Sysmex Corporation
  • TABLE 53key information - Charles River Laboratories International, Inc.
  • TABLE 54key information - QuidelOrtho Corporation
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!